News | April 16, 2026
Anlon Healthcare gets Brickwork rating withdrawal after facility closure
This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities
This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
Through the partnership, she plans to share her experience—from consultation through recovery—across her social media platforms
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck
Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users
Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology
Subscribe To Our Newsletter & Stay Updated
